Dec. 08--Many of the nation's hospitals imperil newborn infants' lives by not
getting their blood tests to laboratories fast enough to flag serious illnesses,
according to a Milwaukee Journal Sentinel investigation.
The special section, titled "Deadly Delays," chronicled the results of the
newspaper's analysis of nearly 3 million screening tests for genetic disorders
from 31 states.
At least 160,000 tests arrived late at laboratories, according to the analysis.
In Wisconsin, nearly 1,800 samples took five or more days to reach the Wisconsin
State Laboratory of Hygiene, where they are screened for 45 different illnesses,
according to the report.
The newspaper said it undertook the eight-month national investigation after an
infant nearly died from an easily treatable condition when the New London
hospital where he was born delayed sending his screening to the Wisconsin State
Laboratory of Hygiene.
The tests involve pricking the baby's heel within a day or two of birth and
collecting small spots of blood on a filter paper card. Hospitals are supposed
to send the cards to state labs within 24 hours.
The newborn screening program, developed 50 years ago, is "a public health
miracle that we should not take for granted," said Dr. Dennis Costakos,
neonatology chairman at Mayo Health System-Franciscan Healthcare in La Crosse.
"The point of newborn screening is to find the kids before they get sick,"
Costakos said during an interview with the Tribune. "For many, the lack of
treatment could mean brain damage or death."
The screening system not only saves infants' lives but also alerts family
members to genetic disorders they may not have known about, Costakos said
The tests also can lower health care costs by treating illnesses early, avoiding
a lifetime of expensive treatment or reducing the tally, he said.
Time is of the essence to diagnose babies with rare and hard-to-detect illnesses
that could cause brain damage, physical disabilities and death. Treatment often
is simple, such as changing feeding or providing vitamins to counter the
Among Journal Sentinel staffer Ellen Gabler's findings:
--Labs in half of the country are shuttered on weekends and holidays, often
delaying analysis of samples of babies born late in the week. For example, the
newspaper reported, a baby born in Colorado on a Friday died before his
screening results alerted doctors to a treatable condition. The results arrived
the day after he died. Another Colorado baby, with the same disease as the first
boy but born on a Tuesday, survived because his tests were screened promptly and
he was treated.
--Hospitals in almost three-fourths of the country are supposed to use overnight
delivery or courier services to send samples to labs. But some use the U.S.
Postal Service's regular mail to save money. About 70 percent of samples at a
Phoenix hospital took five or more days to arrive at the state lab seven miles
--Many hospitals ignore regulations demanding speed but suffer no consequences
when they are late.
--Federal regulators and public health officials have discussed the need to
standardize testing systems across the nation for almost 15 years, with little
action. State programs vary so much that a baby born with a disorder in one
state can suffer damage from a disease that might have been caught in a
--Lab administrators and public health officials in many states, including
Wisconsin, have sought to keep hospitals' track records hidden.
--Hospitals blame delays on a variety of factors, such as new employees' not
knowing the protocol, delays in mail or delivery services, cost-cutting and
holiday and vacation snags. Some "batch" samples, meaning they wait until they
have several to send to labs to save money, even when states or insurance covers
Gundersen Health System in La Crosse and Mayo-Franciscan fared well in the
Journal Sentinel analysis.
Gundersen's samples reached a lab five or more days after being taken in just 29
of 1,414 cases, a 2.05 percent rate, the analysis found. Nearly 83 percent
arrived in three days or fewer.
Dr. Jennifer Kleven, Gundersen's medical director of general pediatrics, said,
"It's always good to get information on how we're doing and how we're doing
compared with other hospitals. We'll do whatever we can to improve."
Kleven attributed Gundersen's low rate of delays to "a great group of nurses,
lab personnel, pharmacists and providers."
The screenings, which Gundersen delivers to the state lab via courier, are
important to detect problems, she said.
"If anything, they over-catch," prompting further review of a possible condition
that later is proved normal, she said.
"They absolutely have caught diseases in tiny babies that we could treat,"
She cited metabolic disorders as an example of early detection that helps
doctors adjust an infant's diet.
"If we don't get it, it could have tragic consequences," she said.
Mayo-Franciscan was beyond five days with only 21 of 926 samples, for a rate of
2.27 percent, according to the Journal Sentinel analysis. Nearly 90 percent were
under three days or less.
Costakos said the screenings find most babies normal, but the chance of finding
even one health problem makes them worthwhile.
"If something is picked up early, it can improve their life or save a life,"
said Costakos, whose investigation of biotinidase in 1990 led to its being one
of the conditions the screenings seek.
The condition results when the body doesn't recycle a vitamin called biotin
needed to break down fats, proteins and carbohydrates, he said.
Babies with the condition, which Costakos said occurs in about 1 in 50,000
births, appear normal at first but may start having seizures four or five days
"We knew if diagnosed within the first two weeks of life, we could save a life
or and prevent neurological disability by placing the baby on high oral doses of
a vitamin. Monthly cost of the vitamin biotin is $1," he said.
Deafness could result if the disease is undetected, Costakos said.
Regarded health care costs, Costakos said, "One must only think of how people
live longer, and healthier, or how we have seen polio become so infrequent
because of modern vaccines.
"Money spent on the health care of neonates divided by the lifespan of the
patient was a bargain compared to medical care for adult patients," he said.
"In standard economic approaches, treatments are considered cost-effective if
they provide a quality-adjusted life year for less than $50 000. In neonatology,
each quality-adjusted life year costs less than $10,000 -- even for infants at
the lowest birth weights," he said.
"Imagine the human and economic benefit of successful prevention, especially for
babies," Costakos said.
Information from stories by Journal Sentinel reporter Ellen Gabler was used in
(c)2013 the La Crosse Tribune (La Crosse, Wis.)
Visit the La Crosse Tribune (La Crosse, Wis.) at www.lacrossetribune.com
Distributed by MCT Information Services